4-[(3-Chloro-4-fluoroanilino)methyl]phenol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-[(3-Chloro-4-fluoroanilino)methyl]phenol
• 化学式: C₁₃H₁₁ClFNO
• mdl: MFCD01826241
• 分子量: 251.68
• InChiKey: GNUSWWQDWKBJCT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• [EN] DIHYDROPYRIMIDIN-2(1H)-ONES AND DIHYDROPYRIMIDIN-2(1H)-THIONES AS INHIBITORS OF SODIUM IODIDE SYMPORTER<br/>[FR] DIHYDROPYRIMIDIN-2(1H)-ONES ET DIHYDROPYRIMIDIN-2(1H)-THIONES COMME INHIBITEURS DU SYMPORT DE L'IODURE DE SODIUM
  申请人：COMMISSARIAT ENERGIE ATOMIQUE

  公开号：WO2014203044A1

  公开（公告）日：2014-12-24

  The invention relates to novel dihydropyrimidin-2(lH)-ones and dihydropyrimidin- 2(lH)-thiones of formula (la). The invention also relates to the use of such compounds as medicaments, and in particular as inhibitors of sodium iodide symporter (NIS) and reducers of iodine transport and/or accumulation into NIS expressing cells. The invention also concerns a pharmaceutical composition comprising at least one compound of formula (la) as active principle.

  这项发明涉及公式(la)的新型二氢嘧啶-2(lH)-酮和二氢嘧啶-2(lH)-硫醚。该发明还涉及将这些化合物用作药物，特别是作为碘化钠共转运蛋白(NIS)的抑制剂和减少碘进入表达NIS的细胞的药物。该发明还涉及一种包含至少一种公式(la)化合物作为活性成分的药物组合物。
• Heterocyclic compounds as inhibitors of the sodium iodide symporter
  申请人：COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

  公开号：EP2738173A1

  公开（公告）日：2014-06-04

  The invention relates to new compounds of formula (I): for their use as medicaments, and in particular as inhibitors of sodium iodide symporter (NIS) and reducers of iodine transport and/or accumulation into NIS-expressing cells. The invention also relates to a pharmaceutical composition comprising at least one compound of formula (I) as active principle. Finally, the present invention relates to specific compounds of formula (I) as such.

  本发明涉及公式（I）的新化合物： 用于作为药物，特别是用作钠碘共转运体（NIS）的抑制剂和减少碘运输和/或积累到表达NIS的细胞内。本发明还涉及至少包含公式（I）中至少一种化合物作为活性成分的制药组合物。最后，本发明涉及公式（I）的特定化合物。
• [EN] HETEROCYCLIC COMPOUNDS AS INHIBITORS OF THE SODIUM IODIDE SYMPORTER<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES COMME INHIBITEURS DU SYMPORT SODIUM/IODURE
  申请人：COMMISSARIAT ENERGIE ATOMIQUE

  公开号：WO2014083529A1

  公开（公告）日：2014-06-05

  The invention relates to new compounds of formula (I): for their use as medicaments, for inhibiting sodium iodide symporter (NIS), and in particular for reducing iodine transport and/or accumulation into NIS-expressing cells. The invention also relates to a pharmaceutical composition comprising at least one compound of formula (I) as active principle. Finally, the present invention relates to specific compounds of formula (I) as such.

  该发明涉及公式(I)的新化合物，用作药物，用于抑制钠碘共转运体(NIS)，尤其是用于减少碘在表达NIS的细胞中的转运和/或积累。该发明还涉及一种药物组合物，其包括至少一种公式(I)化合物作为活性成分。最后，本发明涉及公式(I)的特定化合物。
• DIHYDROPYRIMIDIN-2(1H)-ONES AND DIHYDROPYRIMIDIN-2(1H)-THIONES AS INHIBITORS OF SODIUM IODIDE SYMPORTER
  申请人：COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

  公开号：US20150175556A1

  公开（公告）日：2015-06-25

  The invention relates to novel dihydropyrimidin-2(1H)-ones and dihydropyrimidin-2(1H)-thiones of formula (Ia): The invention also relates to the use of such compounds as medicaments, and in particular as inhibitors of sodium iodide symporter (NIS) and reducers of iodine transport and/or accumulation into NIS expressing cells. The invention also concerns a pharmaceutical composition comprising at least one compound of formula (Ia) as active principle.

  本发明涉及一种新型二氢嘧啶-2(1H)-酮和二氢嘧啶-2(1H)-硫酮，化学式为(Ia)。本发明还涉及将这些化合物用作药物，特别是作为钠碘共转运体(NIS)的抑制剂和减少碘在表达NIS的细胞中的运输和/或积累的药物。本发明还涉及一种包含至少一种化合物(Ia)作为活性成分的药物组合物。
• Heterocyclic Compounds As Inhibitors Of The Sodium Iodide Symporter
  申请人：COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

  公开号：US20150299218A1

  公开（公告）日：2015-10-22

  The invention relates to new compounds of formula (I): for their use as medicaments, for inhibiting sodium iodide symporter (NIS), and in particular for reducing iodine transport and/or accumulation into NIS-expressing cells. The invention also relates to a pharmaceutical composition having at least one compound of formula (I) as active principle. Finally, the present invention relates to specific compounds of formula (I) as such.

  本发明涉及化合物的新公式（I）：用作药物，用于抑制钠碘共转运体（NIS），尤其用于减少碘在表达NIS的细胞中的转运和/或积累。本发明还涉及具有至少一种公式（I）化合物作为活性成分的制药组合物。最后，本发明涉及公式（I）的特定化合物本身。